|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.18 INR | +20.00% |
|
+22.10% | +68.44% |
| Market Cap | 18.52B 194M 169M 158M 145M 273M 278M 1.86B 728M 9.24B 730M 714M 30.46B | P/E 2024 |
22.4x | P/E 2025 | 21.8x |
|---|---|---|---|---|---|
| Enterprise Value | 18.52B 194M 169M 158M 145M 273M 278M 1.86B 728M 9.24B 730M 714M 30.46B | EV / Sales 2024 |
1.27x | EV / Sales 2025 | 1.45x |
| Free-Float |
56.3% | Yield 2024 * |
-
| Yield 2025 | 0.42% |
| 1 day | +20.00% | ||
| 1 week | +25.10% | ||
| Current month | +21.28% | ||
| 1 month | +13.82% | ||
| 3 months | +64.71% | ||
| 6 months | +76.34% | ||
| Current year | +68.44% |
| 1 week | 55 |  | 69.18 |
| 1 month | 51.38 | | 69.18 |
| Current year | 33.05 | | 69.18 |
| 1 year | 33.05 | | 69.18 |
| 3 years | 31.3 | | 100.9 |
| 5 years | 23.6 | | 100.9 |
| 10 years | 7.2 | | 100.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sanjay Suri
CEO | Chief Executive Officer | 58 | 2026-06-30 |
Sushil Suri
CEO | Chief Executive Officer | 62 | 1992-01-31 |
| Director of Finance/CFO | 59 | 2002-04-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Sushil Suri
CHM | Chairman | 62 | 1992-01-31 |
| Director/Board Member | 58 | 2019-08-12 | |
Savita
BRD | Director/Board Member | - | 2020-06-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +20.00% | +25.10% | - | - | 332M | |
| +0.82% | -7.81% | +46.33% | +150.34% | 1T | |
| -0.37% | -5.25% | +47.77% | +49.51% | 613B | |
| +0.11% | -7.03% | +24.10% | +65.64% | 433B | |
| +0.52% | -2.75% | +40.31% | +34.99% | 350B | |
| +0.22% | -4.45% | +31.74% | +39.89% | 292B | |
| +1.89% | -10.23% | +4.31% | +6.47% | 239B | |
| +1.75% | -7.90% | -1.31% | -41.80% | 206B | |
| +1.61% | -2.40% | +27.07% | +57.71% | 204B | |
| +0.10% | -2.77% | +14.05% | +65.99% | 163B | |
| Average | +2.63% | -3.88% | +26.04% | +47.64% | 388.94B | |
| Weighted average by Cap. | +0.56% | -4.34% | +33.71% | +70.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 17.02B 179M 155M 145M 133M 251M 255M 1.71B 669M 8.49B 671M 656M 27.99B | 18.12B 190M 165M 154M 142M 267M 272M 1.82B 712M 9.03B 714M 698M 29.8B |
| Net income | 962M 10.09M 8.77M 8.19M 7.51M 14.17M 14.42M 96.52M 37.8M 480M 37.89M 37.06M 1.58B | 1.18B 12.38M 10.76M 10.05M 9.22M 17.39M 17.69M 118M 46.4M 589M 46.51M 45.48M 1.94B |
| Net Debt | 121M 1.26M 1.1M 1.03M 942K 1.78M 1.81M 12.1M 4.74M 60.11M 4.75M 4.65M 198M | -928K -9.74K -8.46K -7.9K -7.25K -13.67K -13.91K -93.15K -36.48K -463K -36.57K -35.76K -1.53M |
Employees
1,814
Sector
Pharmaceuticals
Calendar
02:45am
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-04 | ₹69.18 | +20.00% | 67,096,271 |
| 26-08-03 | ₹57.65 | +1.07% | 5,950,210 |
| 26-07-31 | ₹57.04 | +1.10% | 2,542,492 |
| 26-07-30 | ₹56.42 | -2.47% | 3,524,842 |
| 26-07-29 | ₹57.85 | +4.61% | 6,074,005 |
- Stock Market
- Stocks
- MOREPENLAB Stock
- MOREPENLAB Stock
Select your edition
All financial news and data tailored to specific country editions
